Aberdeen Asset Management’s Medtronic MDT Stock Holding History

Aberdeen Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$47.1M	Buy	530,228 +24,153	+5%	+$2.04M	0.16%	129
2017 Q1	$40.8M	Buy	506,075 +30,372	+6%	+$2.37M	0.15%	133
2016 Q4	$33.9M	Sell	475,703 -25,330	-5%	-$1.99M	0.13%	152
2016 Q3	$43.3M	Sell	501,033 -9,079	-2%	-$791K	0.15%	93
2016 Q2	$44.3M	Sell	510,112 -8,380	-2%	-$678K	0.16%	87
2016 Q1	$38.9M	Sell	518,492 -25,682	-5%	-$1.93M	0.14%	97
2015 Q4	$39.8M	Buy	544,174 +55,300	+11%	+$4.16M	0.14%	97
2015 Q3	$32.7M	Sell	488,874 -81,872	-14%	-$6.03M	0.11%	110
2015 Q2	$42.3M	Sell	570,746 -19,621	-3%	-$1.5M	0.12%	96
2015 Q1	$46M	Buy	590,367 +125,879	+27%	+$9.54M	0.12%	95
2014 Q4	$33.5M	Sell	464,488 -228,855	-33%	-$15.9M	0.08%	130
2014 Q3	$43M	Sell	693,343 -360,101	-34%	-$22.9M	0.09%	126
2014 Q2	$67.2M	Buy	1,053,444 +948,026	+899%	+$57.6M	0.14%	88
2014 Q1	$6.49M	Sell	105,418 -600	-0.6%	-$35K	0.02%	156
2013 Q4	$6.04M	Hold	106,018	–	–	0.02%	165
2013 Q3	$5.65M	Sell	106,018 -9,210	-8%	-$496K	0.02%	159
2013 Q2	$5.93M	Buy	+115,228	New	+$5.7M	0.02%	153

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Aberdeen Asset Management's MDT Position: Q2 2017 in Review

Aberdeen Asset Management increased its Medtronic (MDT) stake by 4.8% in Q2 2017, buying an estimated $2.04M and bringing the position to 530,228 shares worth $47.1M. The position accounts for 0.16% of the portfolio, ranked #129.

Aberdeen Asset Management first reported a position in MDT in Q2 2013 and has held it in 17 quarters since. The position peaked at $67.2M in Q2 2014. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

Aberdeen Asset Management held 530,228 shares of Medtronic worth $47.1M as of Q2 2017.
Aberdeen Asset Management bought 24,153 Medtronic shares in Q2 2017, an estimated $2.04M.
Medtronic made up 0.16% of Aberdeen Asset Management's portfolio in Q2 2017, its #129 holding.
Aberdeen Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Medtronic position peaked at $67.2M in Q2 2014.
1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.